Pioneering trial of a stem cell therapy begins

10/11/2010 | Wall Street Journal, The

The first patient has been recruited in a clinical trial that will assess the efficacy of a stem cell therapy derived from human embryos in the treatment of spinal cord injuries. The experimental treatment will be administered for 14 days.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
PacificSource
Boise, ID